{
    "data": [
        {
            "id": "3415016",
            "type": "article",
            "attributes": {
                "publishOn": "2015-08-07T16:00:08-04:00",
                "isLockedPro": false,
                "commentCount": 14,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Seeking Alpha's Biotech Weekly: Mylan - Perrigo And Signs Of BioBubbly M&A",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "78505",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": []
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "4523",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/3415016-seeking-alphas-biotech-weekly-mylan-perrigo-and-signs-of-biobubbly-m-and-a"
            }
        },
        {
            "id": "3408876",
            "type": "article",
            "attributes": {
                "publishOn": "2015-08-06T13:31:55-04:00",
                "isLockedPro": false,
                "commentCount": 4,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "M&A Daily: Perrigo, Opko, EMC, And More...",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "40141",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": []
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "4523",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/3408876-m-and-a-daily-perrigo-opko-emc-and-more"
            }
        },
        {
            "id": "3276665",
            "type": "article",
            "attributes": {
                "publishOn": "2015-06-23T04:00:50-04:00",
                "isLockedPro": false,
                "commentCount": 4,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Perrigo's Promising Future: 3 Compelling Reasons To Invest In Perrigo Company",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "89016",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "157533",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "4523",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/3276665-perrigos-promising-future-3-compelling-reasons-to-invest-in-perrigo-company"
            }
        },
        {
            "id": "3240916",
            "type": "article",
            "attributes": {
                "publishOn": "2015-06-07T06:16:49-04:00",
                "isLockedPro": false,
                "commentCount": 63,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "The Love-Hate Drug Triangle Of 2015: A Behavioral Analysis",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "88886",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "156661",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "4523",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/3240916-the-love-hate-drug-triangle-of-2015-a-behavioral-analysis"
            }
        },
        {
            "id": "3092166",
            "type": "article",
            "attributes": {
                "publishOn": "2015-04-22T17:27:16-04:00",
                "isLockedPro": false,
                "commentCount": 4,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Don't Cash In On Perrigo Yet, Upside Still Possible",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "85696",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": []
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "4523",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/3092166-dont-cash-in-on-perrigo-yet-upside-still-possible"
            }
        },
        {
            "id": "2975726",
            "type": "article",
            "attributes": {
                "publishOn": "2015-03-05T08:14:45-05:00",
                "isLockedPro": false,
                "commentCount": 7,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Perrigo - The Upside To This Generic Pharmaceutical Company",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "83286",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "151623",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "4523",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2975726-perrigo-the-upside-to-this-generic-pharmaceutical-company"
            }
        }
    ]
}